David Endicott

David J.
Endicott currently serves as Chief Executive Officer & Director at Alcon AG since 2016, President & Chief Executive Officer at Aerie Pharmaceuticals, Inc. since 2022, Chief Executive Officer at Transcend Medical, Inc., President & Chief Executive Officer at TrueVision Systems, Inc., Chief Executive Officer at Alcon NV, Co-President & Chief Executive Officer at Alcon Research LLC, Chief Executive Officer at PowerVision, Inc., Chief Executive Officer & Director at Alcon Vision LLC since 2018, Director at Advanced Medical Technology Association, Independent Director at MiniMed Group, Inc. starting 2026, and President at Alcon Laboratories, Inc. since 2016.
Former roles include Chief Executive Officer at Ciba Vision Corp., Director at Orexigen Therapeutics, Inc. from 2012 to 2018, Independent Director at ZELTIQ Aesthetics, Inc. from 2016 to 2017, Vice President at Allergan, Inc. from 1986 to 2013, President-Medical Devices at Hospira, Inc., President at Allergan Ltd., and President-Hospira Infusion Systems at Pfizer Inc. Education includes an MBA from the University of Southern California and undergraduate studies at Whitman College.